Summary of Original Version

Encourage the Cabinet for Health and Family Services and Medicaid managed care organizations to permit coverage of United States Food and Drug Administration approved digital therapeutics in order to provide more therapy options and improved compliance and outcomes for individuals going through substance use disorder recovery.